# Correction to: Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir

PMC · DOI: 10.1093/cid/ciae356 · 2024-08-02

## Full-text entities

- **Diseases:** Cytomegalovirus Infection (MESH:D003586)
- **Chemicals:** Valganciclovir (MESH:D000077562), Maribavir (MESH:C400401)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11426256/full.md

---
Source: https://tomesphere.com/paper/PMC11426256